The association of down-regulated toll-like receptor 4 expression with airflow limitation and emphysema in smokers

Respiratory Research

Volumn 13, Issue , 2012, Pages

  Lee, Sei Won ^a,b   Kim, Dal Rae ^b   Kim, Tae Jung ^b   Paik, Jin Ho ^b   Chung, Jin Haeng ^b   Jheon, Sanghoon ^b   Huh, Jin Won ^a   Lee, Jae Ho ^b,c   Lee, Choon Taek ^b,c  

^a University of Ulsan College of Medicine   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

^c Seoul National University College of Medicine   (South Korea)

Author keywords

COPD; Emphysema; Smoking; Toll like receptor

Indexed keywords

CORTICOSTEROID; TOLL LIKE RECEPTOR 4; TLR4 PROTEIN, HUMAN;

ADULT; AGED; ANIMAL TISSUE; ARTICLE; BRONCHUS MUCOSA; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DOWN REGULATION; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS EPITHELIUM; LUNG EMPHYSEMA; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PROTEIN EXPRESSION; RESPIRATORY AIRFLOW; SMOKING; TUBERCULOSIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; EMPHYSEMA; METABOLISM; MIDDLE AGED;

ADULT; AGED; DOWN-REGULATION; EMPHYSEMA; FEMALE; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING; TOLL-LIKE RECEPTOR 4;

MLCS; MLOWN;

EID: 84869239347     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-13-106     Document Type: Article

References (38)

1. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet 2007, 370:765-773. 10.1016/S0140-6736(07)61380-4, 17765526.
2. Murray CJ, Lopez AD, Black R, Mathers CD, Shibuya K, Ezzati M, Salomon JA, Michaud CM, Walker N, Vos T. Global burden of disease 2005: call for collaborators. Lancet 2007, 370:109-110. 10.1016/S0140-6736(07)61064-2, 17630021.
3. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006, 3:e442. 10.1371/journal.pmed.0030442, 1664601, 17132052.
4. American Thoracic Society Cigarette smoking and health. Am J Respir Crit Care Med 1996, 153:861-865. American Thoracic Society.
5. Davis RM, Novotny TE. The epidemiology of cigarette smoking and its impact on chronic obstructive pulmonary disease. Am Rev Respir Dis 1989, 140:S82-S84. 10.1164/ajrccm/140.1.82, 2782765.
6. Burrows B, Knudson RJ, Cline MG, Lebowitz MD. Quantitative relationships between cigarette smoking and ventilatory function. Am Rev Respir Dis 1977, 115:195-205.
7. Fletcher C, Peto R. The natural history of chronic airflow obstruction. Br Med J 1977, 1:1645-1648. 10.1136/bmj.1.6077.1645, 1607732, 871704.
8. Tzortzaki EG, Tsoumakidou M, Makris D, Siafakas NM. Laboratory markers for COPD in "susceptible" smokers. Clin Chim Acta 2006, 364:124-138. 10.1016/j.cca.2005.06.008, 16139829.
9. Ouellette DR. The answer is fifteen percent: what is the question?. Chest 2004, 125:3-5. 10.1378/chest.125.1.3, 14718409.
10. Black LF, Kueppers F. Alpha1-Antitrypsin deficiency in nonsmokers. Am Rev Respir Dis 1978, 117:421-428.
11. Janus ED, Phillips NT, Carrell RW. Smoking, lung function, and alpha 1-antitrypsin deficiency. Lancet 1985, 1:152-154.
12. Siafakas NM, Tzortzaki EG, Sourvinos G, Bouros D, Tzanakis N, Kafatos A, Spandidos D. Microsatellite DNA instability in COPD. Chest 1999, 116:47-51. 10.1378/chest.116.1.47, 10424502.
13. Weiss ST, DeMeo DL, Postma DS. COPD: problems in diagnosis and measurement. Eur Respir J Suppl 2003, 41:4s-12s.
14. Sarir H, Henricks PA, van Houwelingen AH, Nijkamp FP, Folkerts G. Cells, mediators and Toll-like receptors in COPD. Eur J Pharmacol 2008, 585:346-353. 10.1016/j.ejphar.2008.03.009, 18410916.
15. Johnson GB, Brunn GJ, Kodaira Y, Platt JL. Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4. J Immunol 2002, 168:5233-5239.
16. Maes T, Bracke KR, Vermaelen KY, Demedts IK, Joos GF, Pauwels RA, Brusselle GG. Murine TLR4 is implicated in cigarette smoke-induced pulmonary inflammation. Int Arch Allergy Immunol 2006, 141:354-368. 10.1159/000095462, 16940747.
17. Zhang X, Shan P, Jiang G, Cohn L, Lee PJ. Toll-like receptor 4 deficiency causes pulmonary emphysema. J Clin Invest 2006, 116:3050-3059. 10.1172/JCI28139, 1616193, 17053835.
18. Kim DR, Park MY, Lee CS, Shim SH, Yoon HI, Lee JH, Sung MW, Kim YS, Lee CT. Combination of vorinostat and adenovirus-TRAIL exhibits a synergistic antitumor effect by increasing transduction and transcription of TRAIL in lung cancer cells. Cancer Gene Ther 2011, 18:467-477. 10.1038/cgt.2011.11, 21455254.
19. Goddard PR, Nicholson EM, Laszlo G, Watt I. Computed tomography in pulmonary emphysema. Clin Radiol 1982, 33:379-387. 10.1016/S0009-9260(82)80301-2, 7083738.
20. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, et al. Standardisation of spirometry. Eur Respir J 2005, 26:319-338. 10.1183/09031936.05.00034805, 16055882.
21. Huh JW, Kim SY, Lee JH, Lee JS, Van Ta Q, Kim M, Oh YM, Lee YS, Lee SD. Bone marrow cells repair cigarette smoke-induced emphysema in rats. Am J Physiol Lung Cell Mol Physiol 2011, 301:L255-266. 10.1152/ajplung.00253.2010, 21622846.
22. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977, 33:159-174. 10.2307/2529310, 843571.
23. Global Initiative for Chronic Obstructive Lung Disease Workshop report: global strategy for diagnosis, management, and prevention of COPD 2011, Geneva, Switzerland, Global Initiative for Chronic Obstructive Lung Disease.
24. MacRedmond RE, Greene CM, Dorscheid DR, McElvaney NG, O'Neill SJ. Epithelial expression of TLR4 is modulated in COPD and by steroids, salmeterol and cigarette smoke. Respir Res 2007, 8:84. 10.1186/1465-9921-8-84, 2194695, 18034897.
25. Geraghty P, Dabo AJ, D'Armiento J. TLR4 protein contributes to cigarette smoke-induced matrix metalloproteinase-1 (MMP-1) expression in chronic obstructive pulmonary disease. J Biol Chem 2011, 286:30211-30218. 10.1074/jbc.M111.238824, 3191060, 21730072.
26. Pace E, Ferraro M, Minervini MI, Vitulo P, Pipitone L, Chiappara G, Siena L, Montalbano AM, Johnson M, Gjomarkaj M. Beta defensin-2 is reduced in central but not in distal airways of smoker COPD patients. PLoS One 2012, 7:e33601. 10.1371/journal.pone.0033601, 3306426, 22438960.
27. Speletas M, Merentiti V, Kostikas K, Liadaki K, Minas M, Gourgoulianis K, Germenis AE. Association of TLR4-T399I polymorphism with chronic obstructive pulmonary disease in smokers. Clin Dev Immunol 2009, 2009:260286. 2822240, 20169003.
28. Rohde G, Klein W, Arinir U, Hagedorn M, Duerig N, TB T, Gillissen A, Schultze-Werninghaus G, TE J. Association of the ASP299GLY TLR4 polymorphism with COPD. Respir Med 2006, 100:892-896. 10.1016/j.rmed.2005.08.018, 16219455.
29. Knobloch J, Schild K, Jungck D, Urban K, Muller K, Schweda EK, Rupp J, Koch A. The T-helper cell type 1 immune response to gram-negative bacterial infections is impaired in COPD. Am J Respir Crit Care Med 2011, 183:204-214. 10.1164/rccm.201002-0199OC, 20709824.
30. von Scheele I, Larsson K, Dahlen B, Billing B, Skedinger M, Lantz AS, Palmberg L. Toll-like receptor expression in smokers with and without COPD. Respir Med 2011, 105:1222-1230. 10.1016/j.rmed.2011.02.012, 21439805.
31. Baines KJ, Simpson JL, Gibson PG. Innate immune responses are increased in chronic obstructive pulmonary disease. PLoS One 2011, 6:e18426. 10.1371/journal.pone.0018426, 3069087, 21483784.
32. Nadigel J, Prefontaine D, Baglole CJ, Maltais F, Bourbeau J, Eidelman DH, Hamid Q. Cigarette smoke increases TLR4 and TLR9 expression and induces cytokine production from CD8(+) T cells in chronic obstructive pulmonary disease. Respir Res 2011, 12:149. 10.1186/1465-9921-12-149, 3260101, 22070100.
33. An CH, Wang XM, Lam HC, Ifedigbo E, Washko GR, Ryter SW, Choi AM. TLR4 Deficiency Promotes Autophagy during Cigarette Smoke-Induced Pulmonary Emphysema. Am J Physiol Lung Cell Mol Physiol 2012, [Epud ahead of print].
34. Barnes PJ, Shapiro SD, Pauwels RA. Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J 2003, 22:672-688. 10.1183/09031936.03.00040703, 14582923.
35. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO, Pare PD. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004, 350:2645-2653. 10.1056/NEJMoa032158, 15215480.
36. Gould GA, Redpath AT, Ryan M, Warren PM, Best JJ, Flenley DC, MacNee W. Lung CT density correlates with measurements of airflow limitation and the diffusing capacity. Eur Respir J 1991, 4:141-146.
37. Iwasaki A, Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol 2004, 5:987-995. 10.1038/ni1112, 15454922.
38. Nomura F, Akashi S, Sakao Y, Sato S, Kawai T, Matsumoto M, Nakanishi K, Kimoto M, Miyake K, Takeda K, Akira S. Cutting edge: endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface toll-like receptor 4 expression. J Immunol 2000, 164:3476-3479.